Investing.com - Shares of CombiMatrix Corp (NASDAQ:CBMX) rallied on Tuesday and were up about 40% on the home stretch to the closing bell with investors cheering a proposed merger of the company with ...

CombiMatrix Corp (NASDAQ: CBMX), a molecular diagnostics company, announced on Thursday it has begun to explore strategic alternatives, including potential M&A activity and business development ...

To significantly cut operating costs CEO to step down as part of restructuring Co to begin search for new CEO April 19 (Reuters) - Biotechnology firm CombiMatrix Corp said its chief executive officer ...

Welcome to CombiMatrix's Fourth Quarter and 2012 Year-End Conference Call, and thank you for your participation and interest in our company. I plan on making a few brief remarks about what we believe ...

Earlier this afternoon CombiMatrix issued financial results for the 2017 first quarter. If you've not received this news release or would be like to be added to the company's email distribution list, ...

Invitae has agreed to acquire two diagnostics developers, CombiMatrix and Good Start Genetics, for a combined $72 million in cash and stock, in a deal designed to expand the buyer’s diagnostics ...

CombiMatrix Corporation (NASDAQ:CBMX) announced today that it has received a four year contract for $858,298 from NASA’s Ames Research Center to design and test a microfluidic system that incorporates ...

IRVINE, Calif., April 7, 2011 (GLOBE NEWSWIRE) -- CombiMatrix Corporation (Nasdaq:CBMX), a molecular diagnostics laboratory offering genetic array testing, a comprehensive profiling of chromosomes and ...

Acacia Research Corporation announced today that its CombiMatrix group's joint product development partner, Nanomaterials Discovery Corporation (NDC), has been granted U.S. Patent No. 6,683,446, ...

IRVINE, Calif., Nov. 3, 2010 (GLOBE NEWSWIRE) -- CombiMatrix Corporation (Nasdaq:CBMX) announced today that it will release its third quarter 2010 financial results on Wednesday, November 10, 2010.

Acacia Research Corporation announced today that its CombiMatrix group has made commercially available the first microarray designed for the H5N1 "Bird Flu" influenza A virus. The World Health ...

Acacia Research Corporation has announced that its CombiMatrix has entered into a manufacturing-and-distribution agreement with Macrogen, Inc. The agreement establishes Macrogen as a key distributor ...